HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Which is the active moiety of sulfasalazine in ankylosing spondylitis? A randomized, controlled study.

AbstractOBJECTIVE:
To compare the efficacy of sulfasalazine (SSZ) with its two moieties, 5-aminosalicylic acid (ASA) and sulfapyridine (SP), in patients with active ankylosing spondylitis (AS).
METHODS:
A 26-week randomized, observer-blinded, 2-center, controlled study of treatment with either SSZ, ASA, or SP was conducted in 90 patients with active AS. Patients were evaluated at baseline and at monthly intervals, using several clinical and laboratory measures of disease activity. A global assessment of treatment efficacy was made by both patients and observers at the end of the study period.
RESULTS:
There were no significant changes in any of the parameters of disease activity in the ASA treatment group. Levels of serum IgG, IgA, and IgM fell significantly during treatment with SP, but none of the other changes reached statistical significance. Plasma viscosity and IgG and IgA levels fell significantly during treatment with SSZ, as did nocturnal spinal pain and overall spinal pain. Patients and observers reported a favorable outcome after treatment with SSZ or SP significantly more often than with ASA treatment.
CONCLUSION:
SP appears to be the active moiety in AS, although there was a trend suggesting a better outcome in the SSZ group compared with the SP group, perhaps suggesting the importance of a common sulfonamide structure for efficacy.
AuthorsA Taggart, P Gardiner, F McEvoy, R Hopkins, H Bird
JournalArthritis and rheumatism (Arthritis Rheum) Vol. 39 Issue 8 Pg. 1400-5 (Aug 1996) ISSN: 0004-3591 [Print] United States
PMID8702450 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)
Chemical References
  • Aminosalicylic Acids
  • Anti-Inflammatory Agents, Non-Steroidal
  • Dermatologic Agents
  • Sulfasalazine
  • Mesalamine
  • Sulfapyridine
Topics
  • Adolescent
  • Adult
  • Aged
  • Aminosalicylic Acids (pharmacology)
  • Anti-Inflammatory Agents, Non-Steroidal (pharmacology)
  • Binding Sites
  • Dermatologic Agents (pharmacology)
  • Female
  • Humans
  • Male
  • Mesalamine
  • Middle Aged
  • Pain (drug therapy)
  • Single-Blind Method
  • Spondylitis, Ankylosing (drug therapy)
  • Sulfapyridine (pharmacology)
  • Sulfasalazine (chemistry, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: